Norge -
norsk -
Statens legemiddelverk
lymecyclin actavis 300 mg
actavis group ptc ehf - lymesyklin - kapsel, hard - 300 mg
Norge -
norsk -
Statens legemiddelverk
smofkabiven
fresenius kabi norge as - halden - aminosyrer, uspesifisert / glukose / fettemulsjon / elektrolytter - infusjonsvæske, emulsjon
Norge -
norsk -
Statens legemiddelverk
smofkabiven elektrolytfri
fresenius kabi norge as - halden - aminosyrer, uspesifisert / glukose / fettemulsjon - infusjonsvæske, emulsjon
Den europeiske union -
norsk -
EMA (European Medicines Agency)
pifeltro
merck sharp & dohme b.v. - doravirine - hiv-infeksjoner - antivirale midler til systemisk bruk - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
Norge -
norsk -
Statens legemiddelverk
iclusig 15 mg
orifarm as - ponatinibhydroklorid - tablett, filmdrasjert - 15 mg
Norge -
norsk -
Statens legemiddelverk
iclusig 15 mg
abacus medicine a/s - ponatinibhydroklorid - tablett, filmdrasjert - 15 mg
Norge -
norsk -
Statens legemiddelverk
olimel n12e
baxter medical ab - alanin / arginin / aspartinsyre / glutaminsyre / glysin / histidin / isoleucin / leucin / lysinacetat / metionin / fenylalanin / prolin / serin / treonin / tryptofan / tyrosin / valin / natriumacetattrihydrat / natriumglyserofosfat, hydrert / kaliumklorid / magnesiumkloridheksahydrat / glukosemonohydrat / kalsiumkloriddihydrat / soyaolje, renset / olivenolje, renset - infusjonsvæske, emulsjon
Den europeiske union -
norsk -
EMA (European Medicines Agency)
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemiene - lipid modifiserende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.